These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19426397)

  • 21. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
    Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
    J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical significance of quantitation of HBV DNA in serum-comparison of the branched-DNA assay with the second-generation digene hybrid capture assay and long-term observation].
    Jun EJ; Han JY; Choi H; Chang UI; Lee TK; Kim YH; Kim JI; Park SH; Kim JK; Chung KW; Sun HS
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):157-66. PubMed ID: 12499801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk features of HBV in human hepatocarcinogenesis: a nested case-controlled study].
    Zhang F; Shao YF; Gao JD; Xu Y; Liu GT; Xu LB; Wu ZY; Gao WH; Sun ZT
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1482-4. PubMed ID: 18275715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
    Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
    Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
    Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
    Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study.
    Tangkijvanich P; Theamboonlers A; Sriponthong M; Kullavanijaya P; Poovorawan Y
    Am J Gastroenterol; 2003 Nov; 98(11):2500-4. PubMed ID: 14638355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
    Trerè D; Borzio M; Morabito A; Borzio F; Roncalli M; Derenzini M
    Hepatology; 2003 Jan; 37(1):72-8. PubMed ID: 12500191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
    Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
    J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
    Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
    Wu CF; Yu MW; Lin CL; Liu CJ; Shih WL; Tsai KS; Chen CJ
    Carcinogenesis; 2008 Jan; 29(1):106-12. PubMed ID: 17999990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
    Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H
    Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
    Chen CH; Huang GT; Yang PM; Chen PJ; Lai MY; Chen DS; Wang JD; Sheu JC
    Eur J Cancer; 2006 Oct; 42(15):2524-9. PubMed ID: 16920352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
    Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma.
    Choi CS; Cho EY; Park R; Kim SJ; Cho JH; Kim HC
    J Med Virol; 2009 Oct; 81(10):1721-5. PubMed ID: 19697408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.